Details of the Drug Pharmacogenomic Perturbation Atlas

General Information of Drug (ID: DMOHS9P)

• Drug Name: Phenacemide Drug Info
• Synonyms: Acetylureum; Carbanmide; Cetylureum; Comitiadone; Eferon; Efron; Epheron; Epiclase; Felurea; Fenacemid; Fenacemida; Fenacemide;Fenacetamide; Fenilep; Fenised; Fenostenyl; Fenural; Fenurea; Fenurone; Fenylacetylmocovina; Fenytan; Neophedan; Neophenal; Phacetur; Phenacalum; Phenacemidum; Phenacereum; Phenacerum; Phenacetur; Phenacetylcarbamide; Phenacetylurea; Phenarone; Phenicarb; Phenuron; Phenurone; Phenutal; Phenylacetylurea; Phenylacetyluree; Phenyrit; Phetylureum; Carbamide phenylacetate; Fenacemide [DCIT]; Fenylacetylmocovina [Czech]; Phenylacetyluree [French]; A-1348; Alpha-Phenylacetylurea; Fenacemida [INN-Spanish]; Fenacetil-karbamide; Phenacemide [INN:BAN]; Phenacemidum [INN-Latin]; Phenurone (TN); Sym-PHENYLACETYLUREA; N-(Aminocarbonyl)benzeneacetamide; Phenacemide (JAN/INN); N-carbamoyl-2-phenylacetamide; N-(aminocarbonyl)-2-phenylacetamide; (2-phenylacetyl)urea; (Phenylacetyl)urea
• Therapeutic Class: Anticonvulsants
• Cross-matching ID:
  PubChem CID: 4753
  ChEBI ID: CHEMBL918
  CAS Number: CAS 63-98-9
  TTD Drug ID: D07ONP

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name	NES	FDR q-val	Tag %	Leading Edge Genes
Viral protein interaction with cytokine and cytokine re...	2.12	0.00e+0	84/100 (84%)	TNFSF10;CXCL2;CCL19;...
IL-17 signaling pathway	1.95	2.03e-2	84/94 (89.36%)	S100A8;FADD;MMP9;...
Staphylococcus aureus infection	1.83	3.73e-2	72/95 (75.79%)	CFB;KRT18;KRT17;...
Amoebiasis	1.79	4.07e-2	99/102 (97.06%)	COL1A1;CXCL2;CXCL8;...

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone

Osteosarcoma

Cell Line Name	Cellosaurus Accession	Species of Origin	Drug Dosage	Time Point	Details
U-2 OS	CVCL_0042	Homo sapiens	10uM	6H	Hide ▲